PERCEPTIVE ADVISORS LLC Q4 2017 Filing
Filed February 14, 2018
Portfolio Value
$3.0T
Holdings
131
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (131 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —ABEONA THERAPEUTICS INC | 59,662 | $946.0M | 0.03% | |
| 102 | —AFFIMED NV | 668,214 | $869.0M | 0.03% | |
| 103 | —AZURRX BIOPHARMA INC | 227,272 | $841.0M | 0.03% | |
| 104 | —IGNYTA INC | 30,211 | $807.0M | 0.03% | |
| 105 | —ALLIQUA BIOMEDICAL INC | 423,394 | $766.0M | 0.03% | |
| 106 | AFWALIGN TECHNOLOGY INC | 3,448 | $766.0M | 0.03% | |
| 107 | ARNAEURARENA PHARMACEUTICALS INC | 21,978 | $747.0M | 0.02% | |
| 108 | —SUCAMPO PHARMACEUTICALS INC | 40,062 | $719.0M | 0.02% | |
| 109 | ESPRESPERION THERAPEUTICS INC NE | 10,769 | $709.0M | 0.02% | |
| 110 | CNCCENTENE CORP DEL | 6,699 | $676.0M | 0.02% | |
| 111 | —CURIS INC | 951,201 | $666.0M | 0.02% | |
| 112 | RACEFERRARI NV | 6,200 | $650.0M | 0.02% | |
| 113 | —PROTEON THERAPEUTICS INC | 334,116 | $635.0M | 0.02% | |
| 114 | BHCVALEANT PHARMACEUTICALS INTL | 30,092 | $625.0M | 0.02% | |
| 115 | EVHEVOLENT HEALTH INC | 50,000 | $615.0M | 0.02% | |
| 116 | SPPIUSDSPECTRUM PHARMACEUTICALS INC | 32,154 | $609.0M | 0.02% | |
| 117 | XBISPDR S&P BIOTECH ETF SHS PUT 85 01/05/2018 | 600,000 | $579.0M | 0.02% | Put |
| 118 | ONCBEIGENE LTD | 5,700 | $557.0M | 0.02% | |
| 119 | CUTREURCUTERA INC | 11,981 | $543.0M | 0.02% | |
| 120 | MRTXEURMIRATI THERAPEUTICS INC | 29,091 | $531.0M | 0.02% | |
| 121 | VRAYQVIEWRAY INC | 50,000 | $463.0M | 0.02% | |
| 122 | —PERNIX THERAPEUTICS HLDGS IN | 1,000,000 | $421.0M | 0.01% | |
| 123 | HCMHUTCHISON CHINA MEDITECH LTD | 10,000 | $394.0M | 0.01% | |
| 124 | —KERYX BIOPHARMACEUTICALS INC | 83,386 | $388.0M | 0.01% | |
| 125 | —PROGENICS PHARMACEUTICALS IN | 61,850 | $368.0M | 0.01% | |
| 126 | SENS1GBPSENSEONICS HLDGS INC | 115,000 | $306.0M | 0.01% | |
| 127 | —CASI PHARMACEUTICALS INC | 83,682 | $272.0M | 0.01% | |
| 128 | —ZOSANO PHARMA CORP | 500,000 | $260.0M | 0.01% | |
| 129 | —ACASTI PHARMA INC | 186,559 | $176.0M | 0.01% | |
| 130 | —JUNO THERAPEUTICS INC | 300,000 | $93.0M | 0.00% | Call |
| 131 | —CAPRICOR THERAPEUTICS INC | 4,000 | $6.0M | 0.00% |
PreviousPage 2 of 2